Study on the financial performance of companies operating in the pharmaceutical industry in romania

The study aims at determining the financial performance of companies in the pharmaceutical industry between 2009 and 2014 by means of the indicator of the financial return rate, using multiple linear regressions as research method. By analysing the evolution of the share of companies in the pharmace...

Full description

Bibliographic Details
Main Authors: Baltes Nicolae, Minculete (Piko) Georgiana Daniela
Format: Article
Language:English
Published: Vasile Goldis University Press 2016-03-01
Series:Studia Universitatis Vasile Goldis Arad, Seria Stiinte Economice
Subjects:
g19
g39
Online Access:https://doi.org/10.1515/sues-2016-0005
id doaj-d17a526dc81943d99ff61ac0ef458336
record_format Article
spelling doaj-d17a526dc81943d99ff61ac0ef4583362021-09-05T14:00:49ZengVasile Goldis University PressStudia Universitatis Vasile Goldis Arad, Seria Stiinte Economice1584-23392016-03-01261586810.1515/sues-2016-0005sues-2016-0005Study on the financial performance of companies operating in the pharmaceutical industry in romaniaBaltes Nicolae0Minculete (Piko) Georgiana Daniela1„Lucian Blaga” University of Sibiu„Lucian Blaga” University of SibiuThe study aims at determining the financial performance of companies in the pharmaceutical industry between 2009 and 2014 by means of the indicator of the financial return rate, using multiple linear regressions as research method. By analysing the evolution of the share of companies in the pharmaceutical industry based on the trend of the financial rate of return, we can estimate that the number of entities that resort to supporting the financial activities from loans and liabilities is growing in the period under analysis. This is due mainly to the liquidity crisis faced by entities, as a result of the high recovery duration of debts. Also, using the multiple linear regression we can highlight that, the financial return of pharmaceutical companies is positively influenced by their economic profitability, by the equity multiplier and by inflation, and negatively, by the net profit margin.https://doi.org/10.1515/sues-2016-0005financial performancefinancial returneconomic profitabilitythe method of multiple linear regressionequity multipliernet profit marging19g39
collection DOAJ
language English
format Article
sources DOAJ
author Baltes Nicolae
Minculete (Piko) Georgiana Daniela
spellingShingle Baltes Nicolae
Minculete (Piko) Georgiana Daniela
Study on the financial performance of companies operating in the pharmaceutical industry in romania
Studia Universitatis Vasile Goldis Arad, Seria Stiinte Economice
financial performance
financial return
economic profitability
the method of multiple linear regression
equity multiplier
net profit margin
g19
g39
author_facet Baltes Nicolae
Minculete (Piko) Georgiana Daniela
author_sort Baltes Nicolae
title Study on the financial performance of companies operating in the pharmaceutical industry in romania
title_short Study on the financial performance of companies operating in the pharmaceutical industry in romania
title_full Study on the financial performance of companies operating in the pharmaceutical industry in romania
title_fullStr Study on the financial performance of companies operating in the pharmaceutical industry in romania
title_full_unstemmed Study on the financial performance of companies operating in the pharmaceutical industry in romania
title_sort study on the financial performance of companies operating in the pharmaceutical industry in romania
publisher Vasile Goldis University Press
series Studia Universitatis Vasile Goldis Arad, Seria Stiinte Economice
issn 1584-2339
publishDate 2016-03-01
description The study aims at determining the financial performance of companies in the pharmaceutical industry between 2009 and 2014 by means of the indicator of the financial return rate, using multiple linear regressions as research method. By analysing the evolution of the share of companies in the pharmaceutical industry based on the trend of the financial rate of return, we can estimate that the number of entities that resort to supporting the financial activities from loans and liabilities is growing in the period under analysis. This is due mainly to the liquidity crisis faced by entities, as a result of the high recovery duration of debts. Also, using the multiple linear regression we can highlight that, the financial return of pharmaceutical companies is positively influenced by their economic profitability, by the equity multiplier and by inflation, and negatively, by the net profit margin.
topic financial performance
financial return
economic profitability
the method of multiple linear regression
equity multiplier
net profit margin
g19
g39
url https://doi.org/10.1515/sues-2016-0005
work_keys_str_mv AT baltesnicolae studyonthefinancialperformanceofcompaniesoperatinginthepharmaceuticalindustryinromania
AT minculetepikogeorgianadaniela studyonthefinancialperformanceofcompaniesoperatinginthepharmaceuticalindustryinromania
_version_ 1717811297798586368